Page 170 - Profile's Stock Exchange Handbook - 2026 Issue 1

JSE - REM Profile’s Stock Exchange Handbook: 2026 - Issue 1
RATIOS
Remgro Ltd. Ret on SH Fnd 2.57 1.99 8.88 12.93 4.88
Ret On Tot Ass 4.37 4.82 4.85 9.51 4.44
Oper Pft Mgn 6.17 5.32 4.85 4.91 6.76
D:E 0.09 0.10 0.15 0.21 0.23
Int Cover - 6.41 - 2.87 191.53 6.61 5.15
Current Ratio 3.74 2.07 1.86 2.31 2.19
Div Cover 1.09 0.85 7.13 15.52 6.98
NUMBER OF EMPLOYEES: 173
DIRECTORS: Lubbe M, Malherbe J (ne),
ISIN: ZAE000026480 SHORT: REMGRO CODE: REM Moleketi P J (ind ne), Morobe M M (ind ne),
REG NO: 1968/006415/06 FOUNDED: 2000 LISTED: 2000 Neethling P J (alt), Nieuwoudt G G (ne),
NATURE OF BUSINESS: Rantloane L (ind ne), Rupert A (ne),
Vosloo C P (alt), Rupert J P (Chair, ne),
Originally established in the 1940s by the late Dr Anton de Bruyn S E N (Dep Chair, ld ind ne),
Rupert, Remgro’s investment portfolio has evolved Durand J J (CEO), Williams N (CFO)
substantially since then and currently includes investee Scan the QR code to POSTAL ADDRESS: PO Box 456, Stellenbosch,
companies across nine reporting pillars. The Company visit our website 7599
EMAIL: dh@remgro.com
is listed on the Johannesburg Stock Exchange (JSE), WEBSITE: www.remgro.com
operated by the JSE Ltd. in South Africa under the TELEPHONE: 021-888-3000
“Financials – Financial Services – Investment Banking COMPANY SECRETARY: Luche Joubert
and Brokerage Services – Diversified Financial Services” TRANSFER SECRETARY: Computershare Investor Services (Pty) Ltd.
sector, with the share code “REM”. From 3 January 2022, SPONSOR: Rand Merchant Bank (A division of FirstRand Bank Ltd.)
the Company also has a secondary listing on the A2X. AUDITORS: Ernst & Young Inc.
Remgro’s interests consist mainly of investments in BANKERS: First National Bank
the healthcare, consumer products, financial services, CALENDAR Expected Status
infrastructure, industrial and media industries. Next Interim Results Mar 2026 Unconfirmed
Sep 2026
Remgro’s most significant investments are as follows: Next Final Results Nov 2026 Unconfirmed
Unconfirmed
Annual General Meeting
Mediclinic Group Ltd. (Mediclinic) (50.0% interest),
OUTsurance Group Ltd. (OUTsurance Group) (30.6% CAPITAL STRUCTURE Authorised Issued
interest), Community Investment Ventures Holdings (Pty) REM Ords no par val 1 000 000 000 529 217 007
Ltd. (CIVH) (57.0% interest), Heineken Beverages Holdings DISTRIBUTIONS [ZARc]
Ltd. (Heineken Beverages) (18.8% interest), RCL Foods Ltd. Ords no par val Ldt Pay Amt
(RCL Foods) (79.6% interest), Rainbow (80.0% interest), Final No 50 21 Oct 25 27 Oct 25 248.00
FirstRand Ltd. (FirstRand) (1.6% interest), Discovery Special 21 Oct 25 27 Oct 25 200.00
96.00
14 Apr 25
22 Apr 25
Ltd. (Discovery) (7.8% interest), Siqalo Foods (Pty) Ltd. Interim No 49 12 Nov 24 18 Nov 24 184.00
Final No 48
(Siqalo Foods) (100.0% interest), Air Products South Africa LIQUIDITY: Dec25 Avg 6m shares p.w., R900.6m(55.4% p.a.)
(Pty) Ltd. (Air Products) (50.0% interest), TotalEnergies
Marketing South Africa (Pty) Ltd. (TotalEnergies) (24.9% REMGRO 40 Week MA GENF
interest) and Kagiso Tiso Holdings (Pty) Ltd. (KTH) (43.5% 18000
17000
interest). These investments contribute approximately 16000
88% to Remgro’s intrinsic net asset value (INAV after tax). 15000
14000
SECTOR: Fins--FinServcs--InvBnkng&BrokerServcs-- DiversFinServcs 13000
MAJOR ORDINARY SHAREHOLDERS as at 30 Jun 2025 12000
Public Investment Commissioner 16.04% 11000
Ninety One SA (Pty) Ltd. 5.10% 10000
Fairtree Asset Management (Pty) Ltd. 5.01% 9000
2021 2022 2023 2024 2025
FINANCIAL STATISTICS
Jun 25 Jun 24 Jun 23 Jun 22 Jun 21
(R million) Final Final(rst) Final(rst) Final(rst) Final RECENT ANNOUNCEMENTS
Sales 51 506 50 424 48 151 41 876 65 803 Monday, 01 December 2025: Shareholders of Remgro
Op Inc 3 179 2 683 2 335 2 057 4 449 were advised that the Company, which jointly owns
NetIntPd(Rcvd) - 341 147 17 499 1 102 Mediclinic Holdings Ltd. with MSC Mediterranean
Tax 957 948 832 757 1 135 Shipping Company SA through its wholly owned
Minority Int - 117 1 135 1 196 1 840 1 505 subsidiary Investment Holding Ltd. S.à.r.l (“IHL”), has
Att Inc 3 303 1 241 9 624 13 139 3 550 reached an in-principle, non-binding agreement
TotCompIncLoss 6 364 - 205 21 618 13 033 2 543 with IHL regarding a proposed restructuring of their
Hline Erngs-CO 7 827 5 646 6 642 5 816 2 885 respective interests in Mediclinic Holdings
Fixed Ass 12 070 11 052 10 230 17 968 16 889 As negotiations are ongoing and remain subject to
Inv in Assoc 67 132 70 038 75 792 50 771 50 207
Inv & Loans 22 449 20 066 22 747 21 047 14 702 finalisation, Remgro Shareholders were advised that,
Def Tax Asset 277 194 176 219 208 if successfully concluded, the Potential Transaction
Tot Curr Ass 29 438 26 814 23 707 44 478 37 381 may have a material effect on the price of Remgro’s
Ord SH Int 117 039 112 117 115 267 98 443 88 059 securities. Accordingly, Remgro Shareholders were
Minority Int 6 840 7 047 6 521 17 437 15 517 advised to exercise caution when dealing in their
LT Liab 10 419 7 030 11 787 21 128 20 103 Remgro securities until a full announcement is made.
Tot Curr Liab 7 876 12 984 12 740 19 295 17 087 Thursday, 27 November 2025: The board of directors of
PER SHARE STATISTICS (cents per share) Remgro approved the appointment of Christine Ramon
EPS (ZARc) 595.00 224.00 1 710.00 2 328.00 615.77 as an independent non-executive director effective
HEPS-C (ZARc) 1 409.00 1 018.00 1 180.00 1 031.00 500.42 from the close of business on 27 November 2025.
Pct chng p.a. 38.4 - 13.7 14.5 106.0 66.0 Thursday, 27 November 2025: At the 2025 annual general
Tr 5yr av grwth % 42.2 20.8 22.6 20.0 3.8 meeting (“AGM”) of the shareholders of Remgro held
DPS (ZARc) 544.00 264.00 240.00 150.00 88.20 on Thursday, 27 November 2025 all the ordinary and
Pct chng p.a. 106.1 10.0 60.0 70.1 - 56.3 special resolutions proposed were approved by the
Tr 5yr av grwth % 38.0 6.8 6.0 - 4.5 - 17.0 requisite majority of votes.
NAV PS (ZARc) 21 055.00 20 204.00 20 751.00 17 452.00 15 275.16 Wednesday, 26 November 2025: Shareholders are advised
3 Yr Beta 0.73 0.55 0.52 0.84 0.92 that the Independent Communication Authority of
Price High 16 499 16 401 14 840 15 176 12 251 South Africa has approved the Transaction (including
Price Low 12 928 11 600 12 207 10 513 8 128
Price Prd End 15 820 13 609 14 705 12 732 11 231 the issue of an I-ECNS licence), and all other conditions
precedent have been met. The Transaction will be
implemented on 1 December 2025.
168